Floatz logo

Zanubrutinib

AML, Adult

Medical College of WisconsinSmall moleculePhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
81/ 100

Competitive context

29 Active assets in the AML, Adult cohort.

Asset / SponsorPhaseRating
Venetoclax
Institute of Hematology & Blood Diseases Hospital, China
Phase 3BB
Revumenib
Center for International Blood and Marrow Transplant Research
Phase 3BB
Daunorubicin
Institute of Hematology & Blood Diseases Hospital, China
Phase 3BB
Fludarabine
Masonic Cancer Center, University of Minnesota
Phase 3BB
Selinexor
Ruijin Hospital
Phase 2B

View all 41 →

Same molecule, other indications

Zanubrutinib is also rated in:

B-cell non-Hodgkin lymphomaDormant
BBB
Indicative ·
73 / 100
View asset →
splenic marginal zone lymphomaDormant
BB
Indicative ·
68 / 100
View asset →
marginal zone lymphomaDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →